Clinical Trials in Los Angeles

Showing 9181-9200 of 14,465 trials

Biomarkers for Post-Transplant Lymphoproliferative Disorders in Children

NCT02182986

Solid organ transplantation is an important therapeutic option for children with a variety of end stage diseases. However, the same immunosuppressive medications that are required to prevent the child's immune system from attacking and rejecting the transplanted organ can predispose these individuals to developing a very serious cancer that is linked to Epstein-Barr virus (EBV).

Heart TransplantSmall Intestine TransplantKidney Transplant+3 more

National Institute of Allergy and Infectious Diseases (NIAID)944 participantsStarted Aug 2014

Los Angeles, California, United States • Stanford, California, United States • Washington D.C., District of Columbia, United States +4 more locations

WITHDRAWNPhase 2< 1 mile

A Study of Venetoclax Plus Lenalidomide and Dexamethasone for the Treatment of Newly Diagnosed t(11;14)-Positive Multiple Myeloma in Subjects Who Are Ineligible for High-Dose Therapy

NCT03785184

This study will evaluate the safety and preliminary efficacy of venetoclax when combined with lenalidomide and dexamethasone for participants with newly diagnosed, active t(11;14) positive multiple myeloma (MM). This study will consist of 2 parts: Part 1 Dose Escalation and Part 2 Dose Expansion.

Multiple Myeloma

AbbVieStarted Apr 2019

Duarte, California, United States • Greenbrae, California, United States • Los Angeles, California, United States +19 more locations

Biomarkers for Post-Transplant Lymphoproliferative Disorders in Children

A Study of Venetoclax Plus Lenalidomide and Dexamethasone for the Treatment of Newly Diagnosed t(11;14)-Positive Multiple Myeloma in Subjects Who Are Ineligible for High-Dose Therapy

Find Trials by Condition in Los Angeles

Efficacy and Safety Study of PDT Using Photofrin in Unresectable Advanced Perihilar Cholangiocarcinoma (OPUS)

Biomarkers of Fast Acting Therapies in Major Depression

An Extension Study to Evaluate the Long-Term Safety and Tolerability of Ubrogepant in the Treatment of Migraine

Effects of Testosterone Gel on Carbohydrate and Lipid Metabolism In Elderly Obese Men

High-Intensity Focused Ultrasound in Treating Participants With Intermediate and High-risk Prostate Cancer

A Phase IIb Study for ALX-0061 Monotherapy in Subjects With Rheumatoid Arthritis

A Safety Extension Study to Evaluate the Safety and Tolerability of Benralizumab (MEDI-563) in Asthmatic Adults and Adolescents on Inhaled Corticosteroid Plus LABA

BOTOX® Open-Label Treatment in Pediatric Lower Limb Spasticity

Evaluation of the Nicotine Lozenge in Relief of Provoked Acute Craving

Positive Imaging Study for Distant Metastases in Patients With Castration-Resistant Prostate Cancer

QUILT-3.036: AMG 337 in Subjects With Advanced or Metastatic Solid Tumors

QUILT-3.014: A Trial of ABI-011 Administered Weekly in Patients With Advanced Solid Tumors or Lymphomas

Expanded Access Program to Provide Treatment With Pitolisant to Adult Patients in the U.S. With Excessive Daytime Sleepiness Associated With Narcolepsy With or Without Cataplexy

Supplemental Oxygen Study

Long-term Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy in Patients With Major Depressive Disorder

Data Collection of OCT and OCTA-based Ocular Measurements

The Effect Of NS-0200 and NS-0300 Versus Placebo on Weight In Obesity

Open Label, Multi-center Study to Assess the Safety, Tolerability and Pharmacokinetics of CUDC-907 in Subjects With Advanced/Relapsed Solid Tumors